Explore

Global Health Experts Warn of Rising Antifungal Resistance Threat

Global Health Experts Warn of Rising Antifungal Resistance Threat

Infectious disease experts worldwide are raising alarms over a growing resistance to antifungal drugs, a concern highlighted in a recent publication in Nature Medicine. Led by Paul Verweij from Radboud University Medical Centre, the group of over 50 researchers is advocating for the inclusion of antifungal resistance in global antimicrobial resistance (AMR) strategies, which have traditionally focused on bacterial and viral infections. The experts have proposed a five-step plan to address this issue, emphasizing the need for increased awareness, improved surveillance, and investment in new diagnostics and treatments. The rise of drug-resistant fungi, such as Candida auris and Aspergillus fumigatus, poses significant health risks, particularly in vulnerable populations. The experts warn that without integrating antifungal resistance into the 2026 Global Action Plan on AMR, the world risks repeating past mistakes made with antibacterial resistance.

Global Experts Urge Action Against Rising Antifungal Drug Resistance

Global Experts Urge Action Against Rising Antifungal Drug Resistance

Infectious disease experts worldwide are raising alarms over a growing resistance to antifungal drugs, which they describe as a 'silent surge.' This resistance is particularly concerning with pathogens like Candida auris and azole-resistant Aspergillus, which are increasingly found in intensive care units and communities. The experts, led by Paul Verweij from Radboud University Medical Centre, have published a five-step plan in Nature Medicine to address this issue. Their plan aims to influence the World Health Organization's upcoming update to its Global Action Plan on Antimicrobial Resistance (AMR). The proposed measures include raising awareness, improving surveillance, enhancing infection prevention and control, optimizing current antifungal therapies, and increasing investment in new diagnostics and medicines. The experts emphasize the need for support in low- and middle-income countries, where the impact of drug-resistant fungi is particularly severe.

Longhorn Vaccines and Diagnostics Unveils Promising Antibody Data for Combating Antimicrobial Resistance

Longhorn Vaccines and Diagnostics Unveils Promising Antibody Data for Combating Antimicrobial Resistance

Longhorn Vaccines and Diagnostics Unveils Promising Antibody Data for Combating Antimicrobial Resistance

CDC Reports on Tetanus Incidence and Mortality in the U.S. from 2009 to 2023

CDC Reports on Tetanus Incidence and Mortality in the U.S. from 2009 to 2023

The Centers for Disease Control and Prevention (CDC) has released a comprehensive report on tetanus cases in the United States from 2009 to 2023. During this period, 402 cases of tetanus were reported across 47 states and the District of Columbia, resulting in 37 deaths. The annual incidence rate was 0.08 cases per 1 million people, with a higher incidence among males compared to females. The report highlights that adults aged 80 and above had the highest incidence and mortality rates. A significant portion of tetanus cases were linked to acute wounds, with many patients lacking a documented history of receiving a tetanus toxoid-containing vaccine (TTCV). The report also notes that generalized tetanus was the most common clinical type, and a majority of patients required hospitalization, with many needing intensive care and mechanical ventilation.

Study Reveals Madecassic Acid's Potential in Combating Antibiotic Resistance

Study Reveals Madecassic Acid's Potential in Combating Antibiotic Resistance

Recent research has highlighted the potential of madecassic acid, a popular ingredient in Korean skincare, to combat antibiotic-resistant bacteria. The study, published in RSC Medicinal Chemistry, found that madecassic acid may have antibacterial properties, particularly against antibiotic-resistant E.coli. Researchers used computational screening and lab experiments to demonstrate that madecassic acid binds to the respiratory protein complex cytochrome bd, essential for bacterial survival during infection. This binding inhibits the complex's function, potentially killing the bacteria. The study also involved isolating madecassic acid from plant extracts and modifying it to create variants that inhibited bacterial growth. While promising, experts caution that further research is needed before madecassic acid can be used as an antibiotic in healthcare settings.

Study Finds Madecassic Acid May Offer Antibiotic Potential Against Resistant Bacteria

Study Finds Madecassic Acid May Offer Antibiotic Potential Against Resistant Bacteria

Recent research published in RSC Medicinal Chemistry suggests that madecassic acid, a popular ingredient in Korean skincare, may possess antibacterial properties, particularly against antibiotic-resistant E. coli. The study utilized computational screening and lab experiments to demonstrate that madecassic acid binds strongly to the respiratory protein complex cytochrome bd, essential for bacterial survival during infection. This binding inhibits the complex's normal function, potentially killing the bacteria. Researchers isolated madecassic acid from a plant extract in Vietnam and modified it to create variants that inhibited cytochrome bd and shut down bacterial growth. One variant effectively killed E. coli at higher concentrations. Despite these promising findings, experts caution that further research is needed before madecassic acid can be used as an antibiotic.

Study Reveals Long COVID Leaves Distinct Immune Signature in Blood

Study Reveals Long COVID Leaves Distinct Immune Signature in Blood

A recent study published in Communications Medicine has identified distinct immune signatures in individuals suffering from long COVID, a condition where symptoms persist months after initial infection with SARS-CoV-2. Researchers from Australia and Norway conducted the study, which involved analyzing blood samples from participants in Victoria, Australia. The study focused on inflammatory and neurological protein levels, comparing those with long COVID to individuals who had recovered from COVID-19 and those who were SARS-CoV-2-naive. Key findings include elevated levels of interleukin-20 (IL-20) in long COVID patients, indicating ongoing inflammation. The study also found that vaccination did not exacerbate inflammation in these individuals, and protein levels either stabilized or decreased post-vaccination. However, the study was exploratory and small, necessitating further research for validation.

Eswatini's Battle Against Malaria Amid Climate and Migration Challenges

Eswatini's Battle Against Malaria Amid Climate and Migration Challenges

Eswatini, a landlocked nation in southern Africa, is intensifying efforts to eliminate malaria, a disease that remains a significant health challenge due to climate change and migration. The country, formerly known as Swaziland, faces increased malaria transmission as changing weather patterns extend the breeding season for mosquitoes. Informal migration from neighboring countries with higher malaria rates, such as Mozambique, complicates eradication efforts. Eswatini recorded 362 malaria cases in 2024, while Mozambique reported 11.6 million cases. The national malaria program employs various strategies, including mosquito trapping and insecticide testing, to combat the disease. The program also responds rapidly to new cases, deploying teams to affected areas to conduct tests and apply insecticides. Despite challenges like aid cuts and insecticide resistance, Eswatini remains committed to achieving malaria elimination.

BBC Investigation Uncovers HIV Outbreak Linked to Unsafe Practices at Pakistan Hospital

BBC Investigation Uncovers HIV Outbreak Linked to Unsafe Practices at Pakistan Hospital

The BBC Eye team has conducted an undercover investigation revealing serious malpractice at THQ Hospital in Taunsa, Pakistan, linked to an HIV outbreak among children. The investigation found that staff reused syringes and handled medical waste improperly, contributing to the spread of HIV. Despite government intervention and promises of a crackdown, unsafe practices continued, with 331 children testing positive for HIV between November 2024 and October 2025. The documentary 'Stolen lives: Who gave our children HIV?' highlights the scale of the outbreak and the heartbreaking stories of affected families.

Pakistan Hospital's Unsafe Practices Lead to HIV Outbreak Among Children

Pakistan Hospital's Unsafe Practices Lead to HIV Outbreak Among Children

An investigation by BBC News has revealed serious infection control failures at a government hospital in Taunsa, Pakistan, where staff were filmed reusing syringes on children. This malpractice is believed to have contributed to a surge in HIV infections among children. The investigation found that 331 children tested positive for HIV between November 2024 and October 2025, with contaminated needles cited as the likely mode of transmission in over half the cases. Despite evidence, hospital authorities have denied wrongdoing, questioning the authenticity of the footage. The Punjab government had intervened earlier in March 2025, suspending the hospital's head, but unsafe practices reportedly continued.

Syringe Reuse at Pakistan Hospital Leads to HIV Outbreak Among Children

Syringe Reuse at Pakistan Hospital Leads to HIV Outbreak Among Children

An investigation has revealed serious infection control failures at a government hospital in Pakistan, where staff were filmed reusing syringes on children. This malpractice is believed to have contributed to a surge in HIV infections among children. The outbreak was first noticed by a local physician who observed an unusual rise in HIV cases among children treated at the hospital. Despite video evidence of repeated protocol violations, hospital authorities have denied wrongdoing, questioning the authenticity of the footage.

Southwestern College Students Warned of Multidrug-Resistant Tuberculosis Exposure

Southwestern College Students Warned of Multidrug-Resistant Tuberculosis Exposure

Students at Southwestern College in Chula Vista, California, have been notified of potential exposure to multidrug-resistant tuberculosis (MDR-TB) on campus. The exposure reportedly occurred between October 27 and December 14, 2025. The County of San Diego's Tuberculosis Prevention and Care Program issued the notice, emphasizing the difficulty in treating MDR-TB due to its resistance to standard medications. The college is collaborating with the County of San Diego Public Health Services to manage the situation, offering free on-campus TB screenings for those potentially exposed. The case is unrelated to a previous exposure incident at Iglesia Ni Cristo in Miramar.